Skip to main content

Market Overview

30 Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • Ardelyx Inc (NASDAQ: ARDX) rose 44.4 percent to $7.80 in pre-market trading after the company disclosed that its pivotal Phase 3 study of tenapanor hit primary and all secondary endpoints.
  • Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares rose 39.5 percent to $2.33 in the pre-market trading session after jumping 14.38 percent on Wednesday. Infinity Pharma reported an IPI-549 late-breaking presentation at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting.
  • DHX Media Ltd (USA) (NASDAQ: DHXM) rose 33.3 percent to $5.20 in pre-market trading. DHX Media and Amazon Prime Video disclosed a 'large volume content deal.'
  • Smith Micro Software, Inc. (NASDAQ: SMSI) rose 27.8 percent to $2.25 in pre-market trading after gaining 9.32 percent on Wednesday.
  • Anavex Life Sciences Corp. (NASDAQ: AVXL) rose 21.9 percent to $4.90 in the pre-market trading session after the company disclosed that its Phase 2a trial of ANAVEX2-73 met primary and secondary endpoints.
  • Cleantech Solutions International Inc (NASDAQ: CLNT) rose 20.3 percent to $5.98 as the company reported that its subsidiary entered into an exclusivity agreement for a potential acquisition.
  • Karyopharm Therapeutics Inc (NASDAQ: KPTI) rose 14.3 percent to $13.00 in pre-market trading. Karyopharm and Ono Pharmaceutical signed an exclusive license agreement to develop and commercialize selinexor and KPT-8602 in Japan and other countries in Asia.
  • CASI Pharmaceuticals Inc (NASDAQ: CASI) shares rose 11.3 percent to $3.65 in pre-market trading after surging 47.75 percent on Wednesday. CASI Pharmaceuticals Director He Wei-Wu bought 100,000 shares at an average price of $1.95.
  • Kitov Pharmaceuticals Holdings Ltd (ADR) (NASDAQ: KTOV) rose 11.1 percent to $3.50 in pre-market trading after climbing 55.94 percent on Wednesday.
  • Sorrento Therapeutics Inc (NASDAQ: SRNE) shares rose 8.1 percent to $4 in the pre-market trading session after gaining 48.00 percent on Wednesday.
  • Glu Mobile Inc. (NASDAQ: GLUU) shares rose 7.4 percent to $4.08 in pre-market trading. Benchmark downgraded Glu Mobile from Buy to Hold.
  • Babcock & Wilcox Enterprises Inc (NYSE: BW) shares rose 6.8 percent to $4.22 in pre-market trading. VIEX Capital disclosed a 6.4 percent stake in Babcock & Wilcox.
  • Medical Transcription Billing Corp (NASDAQ: MTBC) shares rose 6.4 percent to $3.50 in pre-market trading after climbing 15.03 percent on Wednesday.
  • Onconova Therapeutics Inc (NASDAQ: ONTX) gained 5.8 percent to $2.75 after rising 10.26 percent on Wednesday.
  • ITUS Corp (NASDAQ: ITUS) rose 5.7 percent to $3.33 in pre-market trading after surging 12.10 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares fell 59.8 percent to $2.15 in pre-market trading after the company disclosed that it received a CRL from the FDA regarding its NDA for DSUVIA. The FDA did not approve the NDA in its present form.
  • J.Jill Inc (NYSE: JILL) fell 39.1 percent to $6.05 in pre-market trading after the company issued a weak earnings outlook for the third quarter. The company expects adjusted earnings $0.08-$0.10 per share versus the sell-side consensus estimate of $0.19.
  • Agile Therapeutics Inc (NASDAQ: AGRX) fell 14.4 percent to $4.41 in pre-market trading after rising 3.41 percent on Wednesday.
  • Protagonist Therapeutics Inc (NASDAQ: PTGX) fell 12.7 percent to $17.29 in pre-market trading. Protagonist Therapeutics priced 3.53 million share public offering of common stock at $17 per share.
  • Trevena Inc (NASDAQ: TRVN) fell 8.9 percent to $2.16 in pre-market trading after the company reported restructuring to focus resources on commercial strategy and announced plans to cut workforce by 30 percent.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares fell 8.8 percent to $30.00 in pre-market trading after rising 17.96 percent on Wednesday.
  • Blackhawk Network Holdings Inc (NASDAQ: HAWK) fell 8.6 percent to $40.40 in pre-market trading. Blackhawk reported better-than-expected results for its third quarter, but issued a disappointing forecast for the year.
  • Kandi Technologies Group Inc (NASDAQ: KNDI) shares fell 6.7 percent to $7.70 in pre-market trading following an S-3 filing showing registration for a $300 million mixed securities shelf offering.
  • Domino's Pizza, Inc. (NYSE: DPZ) fell 6.6 percent to $195.50 in the pre-market trading session. Dominos reported upbeat quarterly results and announced a $1.25 billion buyback plan.
  • MannKind Corporation (NASDAQ: MNKD) fell 6.2 percent to $5.13 in pre-market trading after tumbling 18.48 percent on Wednesday.
  • Riot Blockchain Inc (NASDAQ: BIOP) shares fell 6 percent to $8.69 after rising 5.60 percent on Wednesday.
  • Sociedad Quimica y Minera de Chile (ADR) (NYSE: SQM) shares fell 5.2 percent to $54.85 in pre-market trading after slipping 1.72 percent on Wednesday.
  • Athersys, Inc. (NASDAQ: ATHX) fell 5.1 percent to $2.27 in pre-market trading after climbing 7.17 percent on Wednesday.
  • Celsion Corporation (NASDAQ: CLSN) shares fell 5 percent to $5.55 in pre-market trading after rising 26.96 percent on Wednesday.
  • Juniper Networks, Inc. (NYSE: JNPR) fell 4.3 percent to $25.72 in pre-market trading after the company cut its guidance for the third quarter. The company lowered sales outlook from $1.29-$1.35 billion to $1.25-$1.26 billion. Adjusted EPS guidance was reduced from $0.55-$0.61 to $0.54-$0.56.
 

Related Articles (ACRX + AGRX)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com